首页> Gastroenterology> Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease.

Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease.

导出 OA

翻译打印收藏纠错

第一作者： Allan B,Dietz

第一单位： Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: dietz.allan@mayo.edu.

作者： Allan B,Dietz ^[1] ; Eric J,Dozois ^[2] ; Joel G,Fletcher ^[3] ; Greg W,Butler ^[4] ; Darcie,Radel ^[4] ; Amy L,Lightner ^[2] ; Maneesh,Dave ^[5] ; Jessica,Friton ^[6] ; Asha,Nair ^[7] ; Emily T,Camilleri ^[8] ; Amel,Dudakovic ^[8] ; Andre J,van Wijnen ^[8] ; William A,Faubion ^[9]

作者单位： Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: dietz.allan@mayo.edu. ^[1] Department of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota. ^[2] Department of Radiology, Mayo Clinic, Rochester, Minnesota. ^[3] Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. ^[4] Division of Gastroenterology and Liver Disease, Case Western Reserve University School of Medicine, Cleveland, Ohio. ^[5] Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. ^[6] Department of Biomedical Statistics and Information, Mayo Clinic, Rochester, Minnesota. ^[7] Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota. ^[8] Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: faubion.william@mayo.edu. ^[9]

关键词 Cell Therapy Clinical Trial IBD STOMP Trial